Navigation Links
DAS28 in Medical News

RA individuals from lower GDP countries keep working despite worse symptoms than richer countries

.... In the study, HAQ (0-3) was used to measure everyday disability and the das28 (0-10) to measure disease activity. Data concerning work status/disability ...sability aids is required. A higher score indicates greater disability. ** das28 (Disease Activity Score) is an index used by physicians to measure how acti...

63 percent of RA patients suffer psychiatric disorders, with depressive spectrum conditions most likely

...ting Scale and the Montgomery-Asberg Depression Rating Scale. Projective psychological methods were employed for evaluation of cognitive function. * das28 (Disease Activity Score) is an index used by physicians to measure how active an individual's RA is. It assesses number of tender and swollen joints (...

ACTEMRA(R) (tocilizumab) Studies to be Featured at the European League Against Rheumatism (EULAR) Congress

...ct Platform Presentations/Poster Sessions "Tocilizumab Inhibits Structural Joint Damage, Improves Physical Function, and Increases das28 Remission Rates in RA Patients Who Respond Inadequately to Methotrexate: The LITHE Study," will be highlighted in an oral presentation by lead investi...

New Long-Term HUMIRA(R) (adalimumab) Data Show Up to Seven-Year Efficacy with Combination Treatment for Rheumatoid Arthritis

...for at least three consecutive visits; sustained remission was achieved in 42 percent of all patients after a mean of 18 +/- 17 months. das28 is a composite index that includes variables such as the number of tender and swollen joints, specific laboratory values and other measu...

Adalimumab therapy effective in AS, RA and PsA patients refractory to other anti-TNF therapies

...ho have not had prior anti-TNF therapy. RA patients had a mean reduction in das28 (Disease Activity Scale 28) of -1.9 following previous treatment with eithe...eviously undergone anti-TNF therapy achieved ACR50 and had a mean change in das28 of -2.1 after 12 weeks of adalimumab therapy. About the Trials Inve...

50 percent of recent onset RA patients become free of signs and symptoms within 36 weeks

... standard clinical care. Of 169 early RA patients, remission (defined as das28 The researchers achieved these results through implementation of a tight...rage disease duration of 16 weeks (1-52), ESR 33.2 (20.5), CRP 23.5 (26.4), das28 5.1 (1.1), HAQ 1.3 (0.6). ...

Effect of tumor necrosis factor a inhibitors on heart failure risk in RA Patients

..., an increased risk of heart failure was found in patients with low functional capacity and high disease activity. Notably, a 2-point increase in the das28 score resulted in a 1.8-fold increase in heart failure risk. When adjusting for functional capacity and disease activity at follow-up, along with...

Intensity of Rheumatoid Arthritis Significantly Reduced by Pregnancy

...ding to medication use, the Disease Activity Score das28 and the level of inflammation marker C-reactive pr...les (DAS28-CRP-3). The change between the das28 at first and third trimester was used to categoris...oderate and non-responders. The change between the das28 at 6 weeks and 12 or 26 weeks postpartum was used ...

B-Cell Biologic Therapy Could Revolutionize Rheumatoid Arthritis Treatment

...and analyses of the proportions of patients who achieved higher ACR improvement scores--50 percent and 70 percent--showed similar patterns. Changes in das28 at week 24 reflected the ACR response findings, as did the subjects reports of relief from joint pain and stiffness. What's more, subjects in the ritu...
DAS28 in Medical Technology

CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and Pain, but Not CRP

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 28, 2007 - CombinatoRx, Incorporated (NASDAQ: CRXX) today announced preliminary results of its randomized, blinded, placebo-controlled clinical trial of CRx-150 in patients with rheumatoid arthritis (RA). The trial compared CRx-150 plus a disease-modifying ant...

R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies - Results Incongruent

...ib disodium) did not report significantly higher ACR 20, ACR 50, ACR 70 and das28 response rates than the placebo group at three months, and therefore, the t...respond to R788, but the objective and subjective components of the ACR and das28 scores are incongruent, mainly because the reported subjective placebo resp...

Rigel's R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial

...ed for up to 6 months. The groups treated with 100 mg of R788 bid (twice a day) and 150 mg qd (once a day) reported higher ACR 20, ACR 50, ACR 70 and das28 response rates than the placebo group. The efficacy results for the two dosing groups were comparable, although the response rates for the 100 mg bid...

Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients

...he analysis showed that long-term efficacy was maintained in all three patient populations treated with ACTEMRA, as measured by ACR response rates and das28 scores. ACTEMRA monotherapy was proven to be statistically superior to methotrexate in ACR20, ACR50 and ACR70 responses(4) (at six months), accor...

Two-Year Data Reinforce Effect of ACTEMRA(R) (tocilizumab) in Inhibiting Progression of Joint Damage and Improving Physical Function in Rheumatoid Arthritis Patients

... The two-year data from the LITHE study showed that patients treated with ACTEMRA maintained consistently high disease remission rates according to das28 criteria, which measures disease activity in RA patients(2). The study also showed that a greater proportion of patients treated with ACTEMRA (8 mg/kg...

New Study Demonstrated ACTEMRA(R) (tocilizumab) Inhibited Progression of Joint Damage in Rheumatoid Arthritis Patients

...previous studies that patients treated with ACTEMRA experienced an improvement in the signs and symptoms of RA and achieved remission according to the das28 criteria more often than with DMARDs," said Kenneth Bahrt, M.D., Global Medical Director, Autoimmunity, Roche. "The LITHE study not only confirmed the...

ACTEMRA (R) (tocilizumab) Significantly Reduced Signs and Symptoms of Rheumatoid Arthritis in Patients Who Failed Prior Treatments

...ve dose regimen of methotrexate alone. In both studies, nearly one-third of all ACTEMRA (8 mg/kg) patients achieved disease remission (as defined by das28 <2.6(2)) and ACTEMRA was generally well-tolerated compared with existing therapies. About the RADIATE Study RADIATE (RheumAtoiD ArthritIs Study in...

ACTEMRA(R) (tocilizumab) Significantly Reduces Rheumatoid Arthritis Signs and Symptoms Regardless of Previous Therapy in Two New Global Studies

...ACTEMRA patients from both studies reached disease remission (as defined by das28 <2.6(2)). "We are very encouraged by the results of the AMBITION study th...low (DAS28 less than or equal to 3.2), moderate (3.2 (DAS28>5.1). das28 the criteria of the American College of Rheumatology. (3) The EULAR ...

Data From Two Phase 3 Studies Show Anti-TNF Golimumab Significantly Improved Signs and Symptoms of Rheumatoid Arthritis

... of patients in the respective golimumab groups achieved remission based on das28 (CRP), compared with 13 percent of patients receiving placebo plus MTX (p<0...-six percent of patients in the combined golimumab group were classified as das28 (CRP) responders, and 38 percent achieved DAS 28 remission, compared with 6...

International ACTEMRA Rheumatoid Arthritis Study Highlighted in The Lancet

...on of patients treated with ACTEMRA plus methotrexate, with 27.5% achieving das28 less than or equal to 2.6 by 24 weeks. Additionally, results showed that ...of disease activity is interpreted as low (DAS28 moderate (3.2 5.1). das28 corresponds to being in remission according to the criteria of the ...
DAS28 in Biological News

New Actemra data shows significant benefit for patients suffering from rheumatoid arthritis

...ared with only 25% of patients in the control group. Around one in three patients achieved clinical remission in the Actemra group, as assessed using das28 "We are very encouraged by the findings of this new TOWARD data which suggest that Actemra plus DMARDs demonstrates significant improvement in R...
DAS28 in Biological Technology

Phase 3 studies show golimumab significantly improved signs and symptoms of rheumatoid arthritis

...olimumab 50 mg and 100 mg plus MTX groups, respectively, were classified as das28 (using C-reactive protein [CRP]) responders, compared with 52 percent of pa...-six percent of patients in the combined golimumab group were classified as das28 (CRP) responders, and 38 percent achieved DAS 28 remission, compared with 6...
Other Tags
(Date:12/15/2014)... Veretekk.com, Inc. announced today a strategic alliance ... Ocean Avenue has secured exclusive benefit to the strategic ... JM Ocean Avenue is a direct sales company ... and JM International, with partial ownership coming from JM ... , “After nearly 2 decades of servicing the industry ...
(Date:12/15/2014)... South Florida’s leading urgent care provider, ... a daze of hassle, hustle, and bustle that can cause ... to burns when making special meals and heartburn after eating ... at any time. To prevent this season of joy from ... list of helpful and healthful holiday tips to keep the ...
(Date:12/15/2014)... (PRWEB) December 15, 2014 OutMarket ... today released “ Social Media Cheat Sheets ,” a ... community that drives results on the top ten social ... program. It helps drive awareness, engagement, and customer service. ... marketers to make an impact on new networks and ...
(Date:12/15/2014)... Reinberg HealthDay Reporter FRIDAY, ... should reassure the millions of American women who have migraine: ... "There is no association between migraine and breast cancer ... medicine at Harvard Medical School. "There is no positive association, ... no protective effect either." About 18 percent of American ...
(Date:12/15/2014)... The increase in prevalence of disabling hearing ... factors which is contributing to the growth in the global ... treatment of hearing loss and balance disorders are known as ... microphone, speaker and amplifier. The global market is expected to ... the period from 2014 to 2019. Some of the factors ...
Breaking Medicine News(10 mins):Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 2Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 4Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 2Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 3Health News: No Link Between Migraine, Breast Cancer Risk, Study Says 2Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 2Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 3Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 4
(Date:11/18/2014)... , Nov. 18, 2014  The Secure ... Industry Association today jointly announce the formation of ... release of its Identity and Biometric Entry ... The Framework received official support from BORDERPOL, the ... to improve and provide expertise regarding border security, ...
(Date:11/15/2014)... , Nov. 13, 2014  While we may still ... Doctor McCoy used in "Star Trek" to gain instant access ... designed to work with smartphones and tablets for monitoring and ... the healthcare world. This may seem a tad Orwellian to ... to adopt some of these technological opportunities into their healthcare ...
(Date:11/7/2014)... associate professor, biomedical engineering, in the Grove School ... York, have identified a molecule that could lead ... aggressive forms of breast cancer. , Triple negative ... owing to aggressive proliferation and metastasis and a ... team, discovered the overexpression of intercellular adhesion molecule-1 ...
Breaking Biology News(10 mins):Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3Americans May Be Ready for a Brave New World of Healthcare 2Americans May Be Ready for a Brave New World of Healthcare 3Americans May Be Ready for a Brave New World of Healthcare 4
Other Contents